Method for preparing monolithic liquid crystal molecular imprinting column by using chiral molecules as doping agent
A technology of chiral molecules and liquid crystal molecules, applied in chemical instruments and methods, other chemical processes, etc., can solve the problems of incapable of chromatographic stationary phase, difficult to resist HPLC high pressure, etc., and achieve the effect of high imprinting effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Preparation of liquid crystal low cross-linked amlodipine molecularly imprinted monolithic column induced by chiral dopant L-naproxen and evaluation of its imprinting effect.
[0034]A chiral dopant-induced liquid crystal low cross-linked amlodipine molecularly imprinted monolithic column was synthesized by surface imprinting method, and its retention performance was evaluated by connecting it to high performance liquid chromatography under appropriate chromatographic conditions. Synthetic reaction conditions and processing method are as follows:
[0035] Preparation of amlodipine as template molecularly imprinted monolithic column by surface imprinting method:
[0036] a, mass fraction is 0.50% initiator azobisisobutyronitrile dissolved in mass fraction is 18.17% porogen toluene and mass fraction is 51.70% in dodecyl alcohol, then add mass fraction is 29.63% trimethylol propane trimethacrylate, ultrasonicated for 10 min, and the mixture was injected into a stainless s...
Embodiment 2
[0041] Preparation of liquid crystal low cross-linked amlodipine molecularly imprinted monolithic column induced by chiral dopant levoibuprofen and evaluation of its imprinting effect.
[0042] In order to demonstrate that the effect of chiral dopants on the overall imprinting effect of low-crosslinked amlodipine liquid crystal molecules is universal, we synthesized the addition of different chiral dopants (levo-ibuprofen) and the corresponding racemization Molecularly imprinted monolithic column of amlodipine with molecule as dopant. The specific operation steps are as follows:
[0043] a, mass fraction is 0.50% initiator azobisisobutyronitrile dissolved in mass fraction is 18.17% porogen toluene and mass fraction is 51.70% in dodecyl alcohol, then add mass fraction is 29.63% trimethylol propane trimethacrylate, ultrasonicated for 10 min, and the mixture was injected into a stainless steel column (1004.6 mm I.D.), sealed and allowed to stand vertically in a constant temperat...
Embodiment 3
[0048] Preparation of monolithic columns for molecular imprinting of liquid crystals with low cross-linking amlodipine induced by chiral dopant levofloxacin and evaluation of their imprinting effects.
[0049] In order to further demonstrate the generality of the effect of chiral dopants on the imprinting effect of low-crosslinked amlodipine liquid crystal molecular monolithic imprinted columns, we also synthesized amlodipine molecularly imprinted monolithic columns added with levofloxacin dopant. The specific operation steps are as follows:
[0050] A, be that the initiator azobisisobutyronitrile of 0.50% is dissolved in the porogen toluene of 18.17% and the dodecyl alcohol of 51.7% by mass fraction, then add the trimethylol that mass fraction is 29.63% propane trimethacrylate, ultrasonicated for 10 min, and the mixture was injected into a stainless steel column (1004.6 mm I.D.), sealed and allowed to stand vertically in a constant temperature water bath at 48 °C for 14 h. T...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com